Watch the latest episode of focusIR Fireside Chats: Why Edinburgh Investment Trust Is Backing Turnaround Stocks for 2026 Growth. Viewhere

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksHollywood Bwl Regulatory News (BOWL)

Share Price Information for Hollywood Bwl (BOWL)

Share Price is delayed by 15 minutes
Get Live Data
277.00    2.50 (0.91%)
Bid:
274.50
Ask:
275.50
Spread: 1.00 (0.364%)
Market Cap: £464.37m
BOWL Live PriceLast checked at - London Stock Exchange

Intraday Hollywood Bwl Share Chart

Share Buyback Programme

Today 07:00

RNS Number : 4579K
Hollywood Bowl Group plc
01 July 2026
 

1 July 2026

 

 

Hollywood Bowl Group plc

("Hollywood Bowl", the "Company" or the "Group")

 

Share Buyback Programme

 

Further to the Company's half year announcement on 27 May 2026, Hollywood Bowl announces today that it has entered into non-discretionary agreements with Investec and Berenberg to purchase, in aggregate, up to £5 million (excluding any associated costs and stamp duty) of the Company's Ordinary Shares of 1 pence each (the "Shares") and to make trading decisions under the Share Buyback independently of the Company in accordance with certain pre-set parameters. The Share Buyback Programme will commence today and end no later than 30 September 2026. 

The Share Buyback Programme reflects the Group's highly cash generative business model and strong balance sheet. In line with Group's capital allocation policy, the Board believes that a share buyback is an attractive way in which to return excess capital to shareholders while also continuing to invest in growing the business.

The purpose of the Share Buyback Programme is to reduce the share capital of the Company. As such, the Company will cancel any shares purchased. 

This arrangement is in accordance with Chapter 9 of the UK Listing Rules and the Group's general authority to repurchase ordinary shares. The Share Buyback Programme will be conducted within the parameters prescribed by the Market Abuse Regulation 596/2014, the Commission Delegated Regulation (EU) 2016/1052 (both as incorporated into UK domestic law by the European Union (Withdrawal) Act 2018 and as amended by the Market Abuse (Amendment) (EU Exit) Regulations 2019) and with regard to regulatory technical standards for the conditions applicable to buy-back programmes and stabilisation measures. During any closed periods, the Company and its directors have no power to invoke any changes to the programme, and it will be executed at the sole discretion of Investec and Berenberg, as appropriate.

 

Enquiries:

Hollywood Bowl Group PLC

Via Headland

Stephen Burns, Chief Executive Officer

Antony Smith, Chief Financial Officer

Mat Hart, Group Business Development Director

Headland

hollywoodbowl@headlandconsultancy.com

 

Rosh Field / Antonia Pollock

+44 (0)20 3805 4822

 

 

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
 
END
 
 
MSCFLFVERRIIVIR
Date   Source Headline
26th Feb 20217:44 amRNSAdditional Listing
8th Feb 20217:00 amRNSBlock listing Interim Review
29th Jan 202111:26 amRNSResult of AGM
28th Jan 20216:12 pmRNSHolding(s) in Company
18th Jan 20217:00 amRNSDirector/PDMR Shareholding
5th Jan 20219:39 amRNSDirector/PDMR Shareholding
23rd Dec 202010:15 amRNSAnnual Financial Report and Notice of AGM
14th Dec 20207:00 amRNSFinal Results - Year Ended 30 September 2020
27th Nov 20203:59 pmRNSNotice of Results
15th Oct 20207:00 amRNSTrading Statement - Year Ended 30 September 2020
30th Sep 20204:35 pmRNSPrice Monitoring Extension
14th Aug 20205:39 pmRNSCentre reopening update
6th Aug 20207:00 amRNSBlock listing Interim Review
31st Jul 20204:33 pmRNSDelay to reopening of English centres
17th Jul 20203:53 pmRNSCentre reopening update
30th Jun 20204:36 pmRNSPrice Monitoring Extension
26th Jun 20203:48 pmRNSHolding(s) in Company
16th Jun 20205:17 pmRNSHolding(s) in Company
10th Jun 20201:18 pmRNSHolding(s) in Company
9th Jun 20208:47 amRNSHolding(s) in Company
1st Jun 20207:00 amRNSHalf-year Results
12th May 20209:29 amRNSUpdate and Notice of Results
12th May 20207:00 amRNSUpdate and Notice of Results
17th Apr 202012:53 pmRNSDirector/PDMR Shareholding
17th Apr 202011:55 amRNSResults of Placing
17th Apr 20207:00 amRNSProposed Placing of New Ordinary Shares
6th Apr 20204:37 pmRNSPrice Monitoring Extension
3rd Apr 20204:41 pmRNSSecond Price Monitoring Extn
3rd Apr 20204:36 pmRNSPrice Monitoring Extension
2nd Apr 20207:00 amRNSFurther actions in response to COVID-19
1st Apr 202012:03 pmRNSPrice Monitoring Extension
20th Mar 20204:43 pmRNSSecond Price Monitoring Extn
20th Mar 20204:36 pmRNSPrice Monitoring Extension
19th Mar 20204:43 pmRNSSecond Price Monitoring Extn
19th Mar 20204:37 pmRNSPrice Monitoring Extension
17th Mar 20204:40 pmRNSStatement on COVID-19
16th Mar 20207:00 amRNSDirector/PDMR Shareholding
16th Mar 20207:00 amRNSDirector/PDMR Shareholding
9th Mar 202012:54 pmRNSDirector/PDMR Shareholding
6th Mar 20209:03 amRNSHolding(s) in Company
2nd Mar 20201:17 pmRNSDirector/PDMR Shareholding
26th Feb 20209:58 amRNSHolding(s) in Company
6th Feb 20204:38 pmRNSDirector/PDMR Shareholding
6th Feb 20209:10 amRNSGrant of Options under SAYE Scheme
4th Feb 20208:53 amRNSAdditional Listing
30th Jan 20201:51 pmRNSResult of AGM
20th Jan 202012:30 pmRNSDirector/PDMR Shareholding
7th Jan 20204:54 pmRNSDirector/PDMR Shareholding
23rd Dec 201910:32 amRNSAnnual Financial Report and Notice of AGM
20th Dec 201912:23 pmRNSHolding(s) in Company

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.